In this Issue
Ongoing study and innovation seek to determine the ideal roles of these challenging procedures.
CHIEF MEDICAL EDITOR'S PAGE
By Andrew Holden, MBChB, FRANZCR; and Robert Bersin, MD - Guest Chief Medical Editors
The Baptist Memorial Hospital Experience with the Mynx¨ Vascular Closure Device.
By David Wolford, MD, FACC
There has been recent progress in the evaluation of thoracic endovascular grafts—and not just for the treatment of aneurysms.
By Dorothy B. Abel
By Rodney White, MD
Despite improved treatment options, the need for consensus among specialties remains.
By James A. M. Smith, DO
Perspectives on Contemporary Studies on the Treatment of Renal Artery Stenosis and the Role of the CORAL Trial
Michael R. Jaff, DO, FACP, FACC, and Timothy Murphy, MD, discuss the impact of previous studies on the current state of renal artery stenosis therapy and the goals and progress of the landmark CORAL trial.
A novel strategy for the treatment of resistant hypertension.
By Krishna J. Rocha-Singh, MD, FACC, FSCAI, FSVM
A case report demonstrating coil embolization and stent placement as a safe and effective alternative treatment modality to the traditional open aneurysmectomy and revascularization.
By Kak Rae Kim, MD; Hamid Zahiri, DO; Jian Cai, RVT; Richard Wilkerson, MD; Elliott Badder, MD; Luis Queral, MD; and Paul R. Lucas, MD
An overview of the surgical and endovascular options for this rare but treatable condition.
By Benjamin M. Jackson, MD, and Edward Y. Woo, MD
How a combination of two techniques can be used for successful and safe renal artery revascularization.
By Andrew Holden, MBChB, FRANZCR
How CTA can be a useful modality for diagnosing and managing renal artery stenosis for stent placement.
By Michael Wholey, MD, MBA; James Wu, BA; William C.L. Wu, MD, FACC; and Ian Nowak, CRT
The Society for Clinical Vascular Surgery and industry collaborate to bring fellows together in a simulator training competition.
By Jean Bismuth, MD, and Alan B. Lumsden, MD
Dr. Schneider discusses treating CLI patients, additions to the 2009 VIVA meeting, and what we can expect to see from the vascular field in the next few years.